148 related articles for article (PubMed ID: 21721458)
1. Patent foramen ovale and recurrent transient neurological symptoms: a case report and review of literature.
Anamnart C; Poungvarin N
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S264-8. PubMed ID: 21721458
[TBL] [Abstract][Full Text] [Related]
2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
3. Patent foramen ovale and cryptogenic stroke: a matter of age?
Handke M; Harloff A; Bode C; Geibel A
Semin Thromb Hemost; 2009 Jul; 35(5):505-14. PubMed ID: 19739041
[TBL] [Abstract][Full Text] [Related]
4. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study.
Rigatelli G; Dell'avvocata F; Braggion G; Giordan M; Chinaglia M; Cardaioli P
Catheter Cardiovasc Interv; 2008 Dec; 72(7):973-6. PubMed ID: 19021284
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
6. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
[TBL] [Abstract][Full Text] [Related]
8. Patent foramen ovale and cryptogenic stroke: from studies to clinical practice: Position paper of the Italian Chapter, International Society Cardiovascular Ultrasound.
Savino K; Maiello M; Pelliccia F; Ambrosio G; Palmiero P
Int J Clin Pract; 2016 Aug; 70(8):641-8. PubMed ID: 27384340
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
[TBL] [Abstract][Full Text] [Related]
11. Determinants and clinical significance of persistent residual shunting in patients with percutaneous patent foramen ovale closure devices.
Shafi NA; McKay RG; Kiernan FJ; Silverman IE; Ahlquist M; Silverman DI
Int J Cardiol; 2009 Nov; 137(3):314-6. PubMed ID: 19616327
[TBL] [Abstract][Full Text] [Related]
12. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?
Rigatelli G; Aggio S; Cardaioli P; Braggion G; Giordan M; Dell'avvocata F; Chinaglia M; Rigatelli G; Roncon L; Chen JP
JACC Cardiovasc Interv; 2009 Jul; 2(7):655-62. PubMed ID: 19628189
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler.
Jesurum JT; Fuller CJ; Renz J; Krabill KA; Spencer MP; Reisman M
JACC Cardiovasc Interv; 2009 Jun; 2(6):561-7. PubMed ID: 19539262
[TBL] [Abstract][Full Text] [Related]
14. [Interventional closure of persistent foramen ovale in patients after crytogenic stroke].
Chatterjee T; Akin I; Nienaber CA; Rehders TC; Ortak J; Chatterjee A; Ince H
Praxis (Bern 1994); 2010 Oct; 99(20):1203-15. PubMed ID: 20931496
[TBL] [Abstract][Full Text] [Related]
15. PFO closure in children.
Kenny D; Turner M; Martin R
Catheter Cardiovasc Interv; 2008 Apr; 71(5):715. PubMed ID: 18360871
[No Abstract] [Full Text] [Related]
16. Echocardiographic features of PFOs and paradoxical embolism: a complicated puzzle.
Aggeli C; Verveniotis A; Andrikopoulou E; Vavuranakis E; Toutouzas K; Tousoulis D
Int J Cardiovasc Imaging; 2018 Dec; 34(12):1849-1861. PubMed ID: 29956022
[TBL] [Abstract][Full Text] [Related]
17. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
18. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.
von Bardeleben RS; Richter C; Otto J; Himmrich L; Schnabel R; Kampmann C; Rupprecht HJ; Marx J; Hommel G; Münzel T; Horstick G
Int J Cardiol; 2009 May; 134(1):33-41. PubMed ID: 18715659
[TBL] [Abstract][Full Text] [Related]
19. Patent foramen ovale and cryptogenic stroke.
Nakanishi K; Yoshiyama M; Homma S
Trends Cardiovasc Med; 2017 Nov; 27(8):575-581. PubMed ID: 28709812
[TBL] [Abstract][Full Text] [Related]
20. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
